BioCryst Pharmaceuticals
BCRX
#4926
Rank
HK$15.39 B
Marketcap
HK$59.83
Share price
-0.78%
Change (1 day)
6.86%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total assets

Total assets on the balance sheet as of June 2026 : HK$4.37 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are HK$4.37 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31HK$4.03 B-6.05%
2022-12-31HK$4.29 B-6.3%
2021-12-31HK$4.58 B76.75%
2020-12-31HK$2.59 B90.08%
2019-12-31HK$1.36 B18.72%
2018-12-31HK$1.14 B-17.44%
2017-12-31HK$1.39 B99.9%
2016-12-31HK$0.69 B-26.53%
2015-12-31HK$0.94 B-10.67%
2014-12-31HK$1.06 B180.18%
2013-12-31HK$0.37 B-14.89%
2012-12-31HK$0.44 B-30.27%
2011-12-31HK$0.63 B-25.04%
2010-12-31HK$0.85 B-22.74%
2009-12-31HK$1.10 B68.46%
2008-12-31HK$0.65 B-41.19%
2007-12-31HK$1.11 B108.91%
2006-12-31HK$0.53 B-30.78%
2005-12-31HK$0.76 B204.97%
2004-12-31HK$0.25 B8.16%
2003-12-31HK$0.23 B-27.57%
2002-12-31HK$0.32 B-30.11%
2001-12-31HK$0.46 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
HK$387.08 B 8,748.60%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$745.77 B 16,948.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
HK$25.00 B 471.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$23.13 B 428.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$7.49 B 71.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
HK$6.13 B 40.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
HK$77.42 M-98.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
HK$0.16 B-96.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$8.75 B 100.20%๐Ÿ‡บ๐Ÿ‡ธ USA